Goldman Sachs’s Helus Pharma HELP Stock Holding History
Bought
Maintained
Sold
Other funds holding HELP
ACA
DA
Goldman Sachs's HELP Position: Q3 2026 in Review
Goldman Sachs increased its Helus Pharma (HELP) stake by 133% in Q3 2026, buying an estimated $276K and bringing the position to 46,222 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #5625.
Goldman Sachs first reported a position in HELP in Q4 2023 and has held it in 5 quarters since. 110 funds tracked by Wall St. Rank hold HELP as of Q3 2026.
- Goldman Sachs held 46,222 shares of Helus Pharma worth $568K as of Q3 2026.
- Goldman Sachs bought 26,417 Helus Pharma shares in Q3 2026, an estimated $276K.
- Helus Pharma made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #5625 holding.
- Goldman Sachs first reported a position in Helus Pharma in Q4 2023 and has held it in 5 quarters since.
- 110 funds tracked by Wall St. Rank held Helus Pharma as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.